Cover Image

Editorial: Novel biomarkers for anticancer therapy

Saved in:

Bibliographic Details
Main Authors:	Ting Wang (Author), Zhe-Sheng Chen (Author), Chen Shi (Author), Liang Ouyang (Author), Hongtao Xiao (Author)
Format:	Book
Published:	Frontiers Media S.A., 2023-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Editorial: Novel Targets and Biomarkers in Solid Tumors
by: Zhi Shi, et al.
Published: (2019)

Editorial: Chemo-Radiation-Resistance in Cancer Therapy
by: Xiaoping Lin, et al.
Published: (2022)

MicroRNA as an Important Target for Anticancer Drug Development
by: Zhiwen Fu, et al.
Published: (2021)

Design and synthesis of novel oridonin analogues as potent anticancer agents
by: Qing-Kun Shen, et al.
Published: (2018)

Editorial: Cytoskeleton in the focus of anti-cancer therapy: In a search of novel biomarkers and combinatorial therapy approaches
by: I. Vorobjev, et al.
Published: (2022)

Novel fluorescent probes of 10-hydroxyevodiamine: autophagy and apoptosis-inducing anticancer mechanisms
by: Shuqiang Chen, et al.
Published: (2019)

Plasma circRNA microarray profiling identifies novel circRNA biomarkers for the diagnosis of ovarian cancer
by: Lili Ge, et al.
Published: (2022)

Semisynthesis: Bridging natural products and novel anticancer therapies
by: Bharat Goel, et al.
Published: (2024)

Hydroxamic acid - A novel molecule for anticancer therapy
by: Dilipkumar Pal, et al.
Published: (2012)

Editorial on Anticancer Antioxidants
by: Suzana Borovic Sunjic, et al.
Published: (2021)

Editorial: Adaptive immune resistance in cancer therapy
by: Aimin Jiang, et al.
Published: (2023)

CD133, but Not CD44, May Serve as a Novel Biomarker for Differential Diagnosis Between Basal Cell Carcinoma and Trichoblastomas
by: Bi Y, et al.
Published: (2022)

Editorial: Discovering novel anticancer molecules and revealing the pharmacological mechanism of gastrointestinal carcinoma
by: Yong Xia, et al.
Published: (2022)

Design, synthesis, and anticancer evaluation of novel quinoline derivatives of ursolic acid with hydrazide, oxadiazole, and thiadiazole moieties as potent MEK inhibitors
by: Xiao-Yan Jin, et al.
Published: (2019)

Novel Oxovanadium Complex VO(hntdtsc)(NPIP): Anticancer Activity and Mechanism of Action on HeLa Cells
by: Yinliang Bai, et al.
Published: (2021)

Celastrol: A Review of Useful Strategies Overcoming its Limitation in Anticancer Application
by: Jinfeng Shi, et al.
Published: (2020)

Targeting necroptosis in anticancer therapy: mechanisms and modulators
by: Ying Wu, et al.
Published: (2020)

Ceramide-Graphene Oxide Nanoparticles Enhance Cytotoxicity and Decrease HCC Xenograft Development: A Novel Approach for Targeted Cancer Therapy
by: Shi-Bing Wang, et al.
Published: (2019)

Recent progress in DNA methyltransferase inhibitors as anticancer agents
by: Zhixiong Zhang, et al.
Published: (2022)

ACSL4 as a Potential Target and Biomarker for Anticancer: From Molecular Mechanisms to Clinical Therapeutics
by: Jun Hou, et al.
Published: (2022)

KIF2C Is a Novel Prognostic Biomarker and Correlated with Immune Infiltration in Endometrial Cancer
by: Lanfen An, et al.
Published: (2021)

Novel Anticancer Strategies
Published: (2023)

Novel Anticancer Strategies
by: Hassan Bousbaa
Published: (2021)

Editorial: Targeted cancer therapies, from small molecules to antibodies, volume II
by: Chao-Yue Su, et al.
Published: (2023)

Editorial: Anakoinosis: An Innovative Anticancer Therapy Targeting the Aberrant Cancer Tissue Homeostasis
by: Daniel Heudobler, et al.
Published: (2021)

TPD52L2 Is a Prognostic Biomarker and Correlated With Immune Infiltration in Lung Adenocarcinoma
by: Anyuan Zhong, et al.
Published: (2021)

Nanoparticle-mediated synergistic anticancer effect of ferroptosis and photodynamic therapy: Novel insights and perspectives
by: Haiying Wang, et al.
Published: (2023)

Green synthesis of Au nanoparticles by Scutellaria barbata extract for chemo-photothermal anticancer therapy
by: Yinchuan Wang, et al.
Published: (2024)

CCNB1 is a novel prognostic biomarker and promotes proliferation, migration and invasion in Wilms tumor
by: Bin Xiang, et al.
Published: (2023)

Design, synthesis and biological evaluation of novel podophyllotoxin derivatives as tubulin-targeting anticancer agents
by: Yujin Guo, et al.
Published: (2024)

Design, synthesis and anticancer activity of naphthoquinone derivatives
by: Xiao-bao Shen, et al.
Published: (2020)

Novel metabolic and lipidomic biomarkers of sarcopenia
by: Wei‐Hsiang Hsu, et al.
Published: (2024)

Editorial for targets and anticancer drug research
Published: (2017)

Novel Anticancer Strategies II
by: Hassan Bousbaa
Published: (2023)

A novel correction method for modelling parameter-driven autocorrelated time series with count outcome
by: Xiao-Han Xu, et al.
Published: (2024)

The Discovery of Novel PGK1 Activators as Apoptotic Inhibiting and Neuroprotective Agents
by: Shao-Jia Qiang, et al.
Published: (2022)

Carnitine Palmitoyltransferase System: A New Target for Anti-Inflammatory and Anticancer Therapy?
by: Muyun Wang, et al.
Published: (2021)

Rediscovery of Traditional Plant Medicine: An Underestimated Anticancer Drug of Chelerythrine
by: Nianzhi Chen, et al.
Published: (2022)

A novel synthesis of aurones: Their in vitro anticancer activity against breast cancer cell lines and effect on cell cycle, apoptosis and mitochondrial membrane potential
by: Hai Chen, et al.
Published: (2014)

Identification of WD-Repeat Protein 72 as a Novel Prognostic Biomarker in Non-Small-Cell Lung Cancer
by: Guanglin Shi, et al.
Published: (2023)